A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM)
Clinical trial NCT00735436 · TERMINATED
Trial details
- NCT number
- NCT00735436
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2011-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.